Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-04-15Clinical Trial Update: Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine
A completed non-interventional, retrospective multicenter study assessing non-motor symptoms in advanced Parkinson's disease patients alread…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease [Phase 3]
A Phase 3 trial evaluating BF2.649 for excessive daytime sleepiness in Parkinson's disease has completed, with results assessing efficacy an…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of BF2.649 for excessive daytime sleepiness in Parkinson's disease has completed.
-
FDA approval · 2013-04-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Sun Pharmaceutical's carbidopa-levodopa, updating the regulatory approval for this product.
-
FDA approval · 2013-04-05FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for the carbidopa/levodopa/entacapone combination from Sandoz Inc, representing an approved regu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-03FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical Industries’ generic Carbidopa and Levodopa under an ANDA.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects [Phase 2]
Phase 2 trial evaluating safinamide for levodopa-induced dyskinesia in Parkinson's disease subjects has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918) [Phase 3]
An update reports that the MOTION Phase 3 extension trial of safinamide as add-on to a dopamine agonist in early Parkinson's disease has bee…
-
CLINICAL_TRIALS withdrawal · 2013-03-29Clinical Trial Update: Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating droxidopa for freezing of gait in Parkinson's disease has been withdrawn.
-
FDA approval · 2013-03-14FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) from Avvisto Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Tele-diagnostics for Remote Parkinson's Monitoring
A completed clinical trial evaluating tele-diagnostics for remote monitoring in Parkinson's disease, sponsored by Great Lakes NeuroTechnolog…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial evaluating Florbetapir F-18 PET imaging of beta-amyloid in Parkinson's disease patients has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Treatment of Depression in Parkinson's Disease Trial [Phase 2]
Phase 2 trial evaluating a treatment for depression in Parkinson's disease has completed and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) [Phase 2]
Phase 2 study of Cogane (PYM50028) for early-stage Parkinson's disease (CONFIDENT-PD) has completed. Sponsor Phytopharm conducted the trial.
-
FDA approval · 2013-02-08FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic carbidopa and levodopa combination under an Original Application, providing a generic option for Pa…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 3]
This Phase 3 trial update evaluates the efficacy, safety, and tolerability of E2007 in levodopa-treated Parkinson's disease patients with mo…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Embryonic Dopamine Cell Implants for Parkinson's Disease [Phase 3]
Phase 3 trial of embryonic dopamine cell implants for Parkinson disease has completed. No results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: A Study of E2007 In Patients With Parkinson's Disease [Phase 2]
A Phase 2 trial update for the investigational agent E2007 in Parkinson's disease; the study was terminated and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 2]
A Phase 2 trial evaluating long-term safety, tolerability and efficacy of perampanel in Parkinson's disease with motor fluctuations was term…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations [Phase 3]
A Phase 3 study evaluating E2007 as an adjunct to levodopa in Parkinson's disease patients with motor fluctuations was terminated; results w…
-
FDA approval · 2013-02-05FDA Approved: BENZTROPINE MESYLATE — Original Application (Navinta LLC)
FDA approved Navinta LLC's original application for benztropine mesylate, a generic anticholinergic drug indicated for Parkinsonism and drug…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Medication Review in Patients on Anti-parkinson Therapy
A completed clinical trial update assessing medication review in patients on anti-Parkinson therapy.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Effects of Coenzyme Q10 (CoQ) in Parkinson Disease [Phase 3]
Phase 3 trial evaluating coenzyme Q10 in Parkinson disease has terminated with results posted.
-
CLINICAL_TRIALS research · 2013-01-31Clinical Trial Update: Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients [Phase 4]
This entry notes a Phase 4 study investigating how dopamine affects loss aversion behavior in Parkinsonian patients; the current status is n…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: PET Study in Parkinson's Disease Patients [Phase 2]
Phase 2 PET imaging study in Parkinson's disease patients has completed.